Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia

The application of haploidentical hematopoietic stem cell transplantation (HSCT) with mesenchymal stem cell (MSC) infusion as a treatment regimen for severe aplastic anemia (SAA) has been reported to be efficacious in single-arm trials. However, it is difficult to assess without comparing the result...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Zenghui Liu, Xiaoxiong Wu, Shunqing Wang, Linghui Xia, Haowen Xiao, Yonghua Li, Hongbo Li, Yuping Zhang, Duorong Xu, Danian Nie, Yongrong Lai, Bingyi Wu, Dongjun Lin, Xin Du, Zujun Jiang, Yang Gao, Xuekui Gu, Yang Xiao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2020-10-01
coleção:	Therapeutic Advances in Hematology
Acesso em linha:	https://doi.org/10.1177/2040620720965411
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!